EA200900261A1 - Применение эсцина - Google Patents

Применение эсцина

Info

Publication number
EA200900261A1
EA200900261A1 EA200900261A EA200900261A EA200900261A1 EA 200900261 A1 EA200900261 A1 EA 200900261A1 EA 200900261 A EA200900261 A EA 200900261A EA 200900261 A EA200900261 A EA 200900261A EA 200900261 A1 EA200900261 A1 EA 200900261A1
Authority
EA
Eurasian Patent Office
Prior art keywords
escin
caused
manufacture
treatment
type
Prior art date
Application number
EA200900261A
Other languages
English (en)
Other versions
EA015404B1 (ru
Inventor
Андреас Грасзауер
Ева Пришль
Original Assignee
Мариномед Биотекнолоджи Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мариномед Биотекнолоджи Гмбх filed Critical Мариномед Биотекнолоджи Гмбх
Publication of EA200900261A1 publication Critical patent/EA200900261A1/ru
Publication of EA015404B1 publication Critical patent/EA015404B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)

Abstract

Настоящее изобретение представляет использование эсцина для изготовления фармацевтического препарата для лечения болезней, обусловленных или вызванных активированными гранулоцитами, предпочтительно аллергии I или III типа или септического шока.
EA200900261A 2006-08-04 2007-08-03 Применение эсцина EA015404B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06450109A EP1884245A1 (en) 2006-08-04 2006-08-04 Use of Escin
PCT/EP2007/006870 WO2008015007A2 (en) 2006-08-04 2007-08-03 Use of escin

Publications (2)

Publication Number Publication Date
EA200900261A1 true EA200900261A1 (ru) 2009-06-30
EA015404B1 EA015404B1 (ru) 2011-08-30

Family

ID=37969918

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900261A EA015404B1 (ru) 2006-08-04 2007-08-03 Применение эсцина

Country Status (21)

Country Link
US (2) US20100227830A1 (ru)
EP (2) EP1884245A1 (ru)
JP (1) JP5345933B2 (ru)
KR (1) KR20090034946A (ru)
CN (1) CN101500582B (ru)
AU (1) AU2007280625B2 (ru)
BR (1) BRPI0715070B8 (ru)
CA (1) CA2658279C (ru)
DK (1) DK2046345T3 (ru)
EA (1) EA015404B1 (ru)
ES (1) ES2531516T3 (ru)
HR (1) HRP20141243T1 (ru)
IL (1) IL196606A (ru)
MX (1) MX2009000991A (ru)
NZ (1) NZ574249A (ru)
PL (1) PL2046345T3 (ru)
PT (1) PT2046345E (ru)
SI (1) SI2046345T1 (ru)
UA (1) UA94954C2 (ru)
WO (1) WO2008015007A2 (ru)
ZA (1) ZA200900372B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102065869B (zh) * 2008-07-01 2014-10-08 玛丽诺姆德生物技术公司 抗过敏的海洋生物聚合物
EP2186523A1 (en) * 2008-11-18 2010-05-19 Marinomed Biotechnologie GmbH Use of escin for treatment of Type IV hypersensitivity reaction
ES2346844A1 (es) * 2010-03-17 2010-10-20 Ricardo Lombardero Calzon Crema para quemaduras.
WO2012101618A1 (en) 2011-01-28 2012-08-02 Barcelcom Têxteis S.A. Compression stockings and tubes with bioactive agents for the treatment of venous insufficiency and varicose veins
CA2905756C (en) 2013-03-15 2016-11-29 Mary Kay Inc. Cosmetic compositions for reducing the appearance of cellulite or improving skin texture
US9801900B2 (en) 2013-11-22 2017-10-31 Mary Kay Inc. Compositions for sensitive skin
CN104147055A (zh) * 2014-07-08 2014-11-19 武汉爱民制药有限公司 赖氨酸七叶皂苷及其盐在制备治疗i型超敏反应药物中的用途
US20180154777A1 (en) * 2016-12-02 2018-06-07 Faraday&Future Inc. Braking torque blending system and method for automatic emergency braking
IT202100014495A1 (it) * 2021-06-08 2022-12-08 Neilos S R L "Composizione per l’uso nella prevenzione e/o nel trattamento di patologie osteoarticolari"

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1676561U (de) 1954-03-27 1954-05-20 Lutz Kg Maschf Eugen Vorrichtung zum fraesen von nuten u. dgl. mittels einer motor-oberfraese.
DE3402259A1 (de) * 1984-01-24 1985-08-01 Stephan Dr.med. 3000 Hannover Regöczy Therapeutisch wirksames gemisch, insbesondere zur behandlung von infektionskrankheiten im hals-, nasen- ohrenbereich, stimmbandentzuendungen, schwerer heiserkeit und trombophlebitis
DE3445324A1 (de) * 1984-12-12 1986-06-12 Klinge Pharma GmbH, 8000 München Arzneimittelkombination mit synergistischer wirkung
IT1252866B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli con acidi policarbossilici atti alla modulazione dei mastociti nei processi infiammatori su base neuroimmunogenica
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6759515B1 (en) * 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6630305B1 (en) * 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) * 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6943236B2 (en) * 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6894146B1 (en) * 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7049063B2 (en) * 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6858204B2 (en) * 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) * 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Also Published As

Publication number Publication date
BRPI0715070A2 (pt) 2013-06-25
WO2008015007A2 (en) 2008-02-07
CN101500582B (zh) 2011-08-24
EP2046345B1 (en) 2014-12-10
BRPI0715070B8 (pt) 2021-05-25
JP5345933B2 (ja) 2013-11-20
CN101500582A (zh) 2009-08-05
US20100227830A1 (en) 2010-09-09
CA2658279A1 (en) 2008-02-07
IL196606A0 (en) 2009-11-18
DK2046345T3 (en) 2015-01-26
WO2008015007A3 (en) 2008-04-03
JP2009545623A (ja) 2009-12-24
ZA200900372B (en) 2009-12-30
PT2046345E (pt) 2014-12-26
AU2007280625B2 (en) 2012-05-17
ES2531516T3 (es) 2015-03-16
EP2046345A2 (en) 2009-04-15
KR20090034946A (ko) 2009-04-08
PL2046345T3 (pl) 2015-05-29
HRP20141243T1 (hr) 2015-02-13
EP1884245A1 (en) 2008-02-06
SI2046345T1 (sl) 2015-03-31
NZ574249A (en) 2011-04-29
IL196606A (en) 2015-08-31
UA94954C2 (ru) 2011-06-25
AU2007280625A1 (en) 2008-02-07
US20170014465A1 (en) 2017-01-19
BRPI0715070B1 (pt) 2021-04-13
EA015404B1 (ru) 2011-08-30
MX2009000991A (es) 2009-04-16
US9993512B2 (en) 2018-06-12
CA2658279C (en) 2014-10-28

Similar Documents

Publication Publication Date Title
EA200900261A1 (ru) Применение эсцина
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
ATE488232T1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
WO2009036175A3 (en) F1f0-atpase inhibitors and related methods
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
ES2352576T8 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana.
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
EA201000903A1 (ru) Антитела к pcrv-антигену pseudomonas aeruginosa
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
MA32505B1 (fr) 5-alcynyl-pyrimidines
BRPI0605926A2 (pt) ciclopentanos substituìdos ou ciclopentanonas como agentes terapêuticos
GT201100300A (es) Piperidinas sustituidas
WO2009124962A3 (en) Sulfonamides
EA200801425A1 (ru) Диазепиноны
DOP2006000024A (es) Tiazolidinonas, su preparación y su uso como medicamento
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
WO2007115929A8 (de) Thiazolyl-dihydro-quinazoline
DK1670903T3 (da) Behandling af neurodegenerative sygdomme

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM